67
Participants
Start Date
May 18, 2018
Primary Completion Date
April 11, 2019
Study Completion Date
April 25, 2019
Nicotine patch
FDA-approved smoking cessation pharmacotherapy
Varenicline
FDA-approved smoking cessation pharmacotherapy
Nicotine metabolism
Information on nicotine metabolism will be used to inform selection of medication.
Genetically-informed lung cancer risk score
This intervention uses information from a person's genes and smoking and family medical histories to estimate lung cancer risk compared to current smokers.
"NCI Clearing the Air"
A booklet-led intervention designed by the NCI to support cessation at any stage of a quitter's journey, whether they are still thinking about quitting, have made the decision to quit, or have already taken steps to quit and just need help maintaining their new lifestyle.
Vanderbilt University Medical Center, Nashville
Collaborators (1)
Meharry Medical College
OTHER
Tennessee State University
OTHER
Vanderbilt University Medical Center
OTHER